These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 1864220)

  • 41. [Arterial hypertension and obesity].
    Cattin Y; Guelpa G
    Schweiz Rundsch Med Prax; 1990 May; 79(20):620-6. PubMed ID: 2190294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity and hypertension.
    Dustan HP
    Diabetes Care; 1991 Jun; 14(6):488-504. PubMed ID: 1864221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obesity, metabolism, and the sympathetic nervous system.
    Landsberg L; Krieger DR
    Am J Hypertens; 1989 Mar; 2(3 Pt 2):125S-132S. PubMed ID: 2647103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Function of Perivascular Nerves in Insulin Resistance-induced Hypertension].
    Takatori S
    Yakugaku Zasshi; 2017; 137(11):1367-1371. PubMed ID: 29093373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans.
    Vollenweider P; Randin D; Tappy L; Jéquier E; Nicod P; Scherrer U
    J Clin Invest; 1994 Jun; 93(6):2365-71. PubMed ID: 8200969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Augmented Endothelial-Specific L-Arginine Transport Blunts the Contribution of the Sympathetic Nervous System to Obesity Induced Hypertension in Mice.
    Rajapakse NW; Karim F; Evans RG; Kaye DM; Head GA
    PLoS One; 2015; 10(7):e0131424. PubMed ID: 26186712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obesity hypertension, salt sensitivity and insulin resistance.
    Rocchini AP
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):287-94. PubMed ID: 11213538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Obesity-associated hypertension. Hyperinsulinemia and renal mechanisms.
    Hall JE; Brands MW; Hildebrandt DA; Mizelle HL
    Hypertension; 1992 Jan; 19(1 Suppl):I45-55. PubMed ID: 1730454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM.
    Tack CJ; Smits P; Willemsen JJ; Lenders JW; Thien T; Lutterman JA
    Diabetes; 1996 Jan; 45(1):15-22. PubMed ID: 8522054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the Autonomic Nervous System in the Hemodynamic Response to Hyperinsulinemia-Implications for Obesity and Insulin Resistance.
    Limberg JK; Soares RN; Padilla J
    Curr Diab Rep; 2022 Apr; 22(4):169-175. PubMed ID: 35247145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential blood pressure effects of oral glucose and intravenous L-arginine in healthy lean normotensive and obese hypertensive subjects.
    Castejon AM; Hoffmann IS; Jimenez E; Cubeddu RJ; Baldonedo RM; Cubeddu LX
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S133-6. PubMed ID: 11986911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential effects of insulin on sympathetic nerve activity in agouti obese mice.
    Morgan DA; Rahmouni K
    J Hypertens; 2010 Sep; 28(9):1913-9. PubMed ID: 20577122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Insulin, as a regulating factor of blood pressure].
    Hamada Y; Ikegami H; Ogihara T
    Nihon Rinsho; 1997 Aug; 55(8):1943-9. PubMed ID: 9284405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperinsulinemia in hypertension: increased secretion, reduced clearance or both?
    Giugliano D; Quatraro A; Minei A; De Rosa N; Coppola L; D'Onofrio F
    J Endocrinol Invest; 1993 May; 16(5):315-21. PubMed ID: 8320421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support.
    Zemel MB; Peuler JD; Sowers JR; Simpson L
    Am J Physiol; 1992 Mar; 262(3 Pt 1):E368-71. PubMed ID: 1550229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin resistance--not hyperinsulinemia--is pathogenic in essential hypertension.
    McCarty MF
    Med Hypotheses; 1994 Apr; 42(4):226-36. PubMed ID: 8072428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mediators of sympathetic activation in metabolic syndrome obesity.
    Straznicky NE; Eikelis N; Lambert EA; Esler MD
    Curr Hypertens Rep; 2008 Dec; 10(6):440-7. PubMed ID: 18959829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperinsulinemia, family history of hypertension, and essential hypertension.
    Grandi AM; Gaudio G; Fachinetti A; Bianchi L; Nardo B; Zanzi P; Ceriani L; Guasti L; Venco A
    Am J Hypertens; 1996 Aug; 9(8):732-8. PubMed ID: 8862218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.